News & Events

January, 2014 – Branding Changes for MII Devices
To better differentiate the two vascular closure devices offered by MII, the company has rebranded the VCD produced by the company, establishing CombiClose and ControlClose as the names of the products offered. CombiClose is the original device developed by the company; it provides the flexibility of a two-in-one introducer sheath and closure device. This saves the hospital money and saves time by not having to introduce another device to the procedure. CombiClose can be used as a closure only device as well. Both methods provide closure over wire for the physician. ControlClose adds a cuff stabilizer to the original version, and is intended as a closure only device. The cuff stabilizer provides for direct positioning of the extravascular SIS component as the device is deployed.

December, 2013 – Eamonn Hobbs joins MII as Board Chair
Mr. Hobbs brings to Morris Innovative more than 30 years of leadership experience in a number of medical technology industry segments including interventional radiology, oncology, interventional cardiology, surgery, gastroenterology and medical device/pharmaceutical combination products. After graduating from the University of Massachusetts-Lowell in 1980 with a degree in Plastics Engineering, Mr. Hobbs went to work as a Product Development Engineer with Cook Incorporated. He co-founded AngioDynamics in 1988 and served as the Company’s President and CEO until 2008. During his tenure, he built the Company into a global market leader with more than $200 million in sales and 700 employees. In 2009 he transitioned from Delcath Systems, Inc. Board of Directors member to become President and CEO and served as Chairman on the Medical Device Manufacturers Association (MDMA) Board of Directors from 2010 to 2013. In addition to Morris Innovative, Mr. Hobbs also is Chairman of the Board of Marvao Medical, Inc., and is a member of the Board of Directors of Antares Pharmaceuticals (NASDAQ: ATRS); Harmonic Medical, Inc. the MDMA and the Glens Falls (NY) Hospital.

FISH Abstract to be presented at PVSS Winter Meeting
Dr. Gregory Skerrett, of El Paso TX, will present the following abstract: “Fishing For A Safe and Effective Vascular Closure Device: A Single Institution’s Experience With the Femoral Introducer Sheath and Hemostasis (FISH) Device” at the Peripheral Vascular Surgery Society’s winter meeting. The meeting will be held at the Canyons in Park City Utah, January 31 – February 3rd, 2013. For more information on the meeting, please see: